Skip to content
HowShorted

Avita Medical, Inc. short interest in 2023

In 2023, Avita Medical, Inc.'s disclosed short interest ran from 1.44% of shares outstanding on 13 Jan 2023 to 2.29% on 29 Dec 2023, a change of +0.85 percentage points. The year's high was 5.02% on 14 Jul 2023 and its low 1.44% on 13 Jan 2023, averaging 2.73% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.09 days on 31 Aug 2023. Full history: Avita Medical, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Avita Medical, Inc. in 2023

2023 in figures

Start of year
1.44% (13 Jan 2023)
End of year
2.29% (29 Dec 2023)
Change
+0.85 pp
High
5.02% (14 Jul 2023)
Low
1.44% (13 Jan 2023)
Average
2.73%
Highest days to cover
9.09 (31 Aug 2023)
SEC filings marked
8

Every report in 2023

Avita Medical, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20231.44%5.71
31 Jan 20231.66%3.82
15 Feb 20231.76%4.57
28 Feb 20232.48%2.2010-K filed
15 Mar 20232.67%3.55
31 Mar 20232.30%4.28
14 Apr 20232.78%3.84
28 Apr 20232.16%2.77
15 May 20231.83%1.8110-Q filed, results (8-K)
31 May 20231.96%3.00
15 Jun 20232.21%1.94
30 Jun 20234.65%2.00
14 Jul 20235.02%4.16
31 Jul 20233.82%4.77
15 Aug 20233.62%5.0710-Q filed, results (8-K)
31 Aug 20233.67%9.09
15 Sep 20233.68%8.82
29 Sep 20233.57%8.31
13 Oct 20232.87%2.20
31 Oct 20232.29%3.68results (8-K)
15 Nov 20232.44%3.2310-Q filed, results (8-K)
30 Nov 20232.32%2.83
15 Dec 20232.00%3.82
29 Dec 20232.29%4.67

See also: Avita Medical, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.